CA2151443A1 - Derives de cycloheptimidazole; mode de fabrication et agents therapeutiques en contenant - Google Patents

Derives de cycloheptimidazole; mode de fabrication et agents therapeutiques en contenant

Info

Publication number
CA2151443A1
CA2151443A1 CA002151443A CA2151443A CA2151443A1 CA 2151443 A1 CA2151443 A1 CA 2151443A1 CA 002151443 A CA002151443 A CA 002151443A CA 2151443 A CA2151443 A CA 2151443A CA 2151443 A1 CA2151443 A1 CA 2151443A1
Authority
CA
Canada
Prior art keywords
compounds
manufacturing
therapeutic agents
same
agents containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002151443A
Other languages
English (en)
Other versions
CA2151443C (fr
Inventor
Tsuyoshi Tomiyama
Akira Tomiyama
Takashi Yanagisawa
Shuichi Wakabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kotobuki Seiyaku Co Ltd
Original Assignee
Kotobuki Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kotobuki Seiyaku Co Ltd filed Critical Kotobuki Seiyaku Co Ltd
Publication of CA2151443A1 publication Critical patent/CA2151443A1/fr
Application granted granted Critical
Publication of CA2151443C publication Critical patent/CA2151443C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA002151443A 1994-07-27 1995-06-09 Derives de cycloheptimidazole; mode de fabrication et agents therapeutiques en contenant Expired - Fee Related CA2151443C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP175234/94 1994-07-27
JP6175234A JPH0834780A (ja) 1994-07-27 1994-07-27 シクロヘプトイミダゾ−ル誘導体及びその製造方法並びにこれを含有する薬剤

Publications (2)

Publication Number Publication Date
CA2151443A1 true CA2151443A1 (fr) 1996-01-28
CA2151443C CA2151443C (fr) 2005-01-11

Family

ID=15992613

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002151443A Expired - Fee Related CA2151443C (fr) 1994-07-27 1995-06-09 Derives de cycloheptimidazole; mode de fabrication et agents therapeutiques en contenant

Country Status (5)

Country Link
JP (1) JPH0834780A (fr)
CN (1) CN1123276A (fr)
CA (1) CA2151443C (fr)
CH (1) CH689163A5 (fr)
TW (1) TW307759B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105513B2 (en) 2002-08-07 2006-09-12 Sanofi-Avertis Deutschland Gmbh Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105513B2 (en) 2002-08-07 2006-09-12 Sanofi-Avertis Deutschland Gmbh Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals

Also Published As

Publication number Publication date
CN1123276A (zh) 1996-05-29
CH689163A5 (de) 1998-11-13
TW307759B (fr) 1997-06-11
CA2151443C (fr) 2005-01-11
JPH0834780A (ja) 1996-02-06

Similar Documents

Publication Publication Date Title
CA2230931A1 (fr) Nouvelles 4-(oxyalcoxyphenyl)-3-oxy-piperidines utiles pour traiter l'insuffisance cardiaque et renale
EP0487745A4 (en) Pyridine derivative with angiotensin ii antagonism
TW369533B (en) Quinoline compounds, process for preparing them and pharmaceutical composition containing them
CA2196640A1 (fr) Derives de substitution de la quinazoline
CA2165819A1 (fr) Derives de dc-89
EP0795548A4 (fr) Derives de la quinazoline et leurs emplois
HK1018208A1 (en) Naphthyl-substituted benzimidazole derivatives as anticoagulants
CO4900064A1 (es) Derivados de la 4-hidroxi-piperidina
CA2176935A1 (fr) Arylpiperazines derivees d'indole comme ligands pour les recepteurs 5 ht1-like 5 ht1b et 5 ht1d
DE69401716D1 (de) Imidazo [1,2-a] pyrasin-4-on-derivate welche als ampa und nmda receptor antagonisten dienen
PL340658A1 (en) Derivatives of biphenylamidine
NO974400L (no) Kombinasjonspreparater inneholdende benazepril eller benazeprilat og valsartan
EP0829478A3 (fr) Dérivés de N-benzylimidazolium et N-benzyltriazolium, leur préparation et leur utilisation comme agents anti-fongiques et anti-mycotiques
CA2182477A1 (fr) Derives pyridyl-imidazoliques et leurs procedes de preparation
CA2151443A1 (fr) Derives de cycloheptimidazole; mode de fabrication et agents therapeutiques en contenant
HK1044155A1 (en) Bicyclic vasopressin agonists.
EP1043311A4 (fr) Derives de biphenylamidine
CA2401952A1 (fr) Pyrano-indoles destines au traitement du glaucome
CA2214386A1 (fr) Derives de thiazolidinone optiquement actifs
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
CA2285535A1 (fr) Derive de benzimidazole
SE9704770D0 (sv) New use
CA2349452A1 (fr) Medicaments contre la dependance aux drogues
CA2389156A1 (fr) Derives de benzamidine
ES2168062A1 (es) Composiciones para control de cucarachas

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130611